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preferably using time trade-off, by a representative
sample from the general public. For the GBD-1990, 
disability weights (DWs) were derived for disease-speciﬁc
health state descriptions from an expert panel using
person trade-off. QALY values and DWs, respectively, are
combined with life-years directly and may be discounted,
whereas DALYs additionally included age weights.
RESULTS: We argue that, though apparent, the various
valuation methods and respondent panels are not the
most important differences. The important novelty of
DALYs lies in the derivation of disease speciﬁc disability
weights. Disease labeling adds information to an 
otherwise generic health state description and may have
added to the validity of the weights, but also disclosed
critical problems with the assumed utility independence
of survival and quality of life. The standard QALY
approach of summing separately valued one-year periods
appeared not to work for diseases characterized by rapid
transitions through different health states. CONCLU-
SION: The problems with DALYs uncovered some impor-
tant limitations of the standard QALY approach. This
may have important methodological implications for the
evaluation of the effects of interventions for attack-type
and short duration diseases.
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OBJECTIVE: Assessing Treatment Satisfaction (TS) has
become an important outcome for many trials and may
be the critical health outcome for differentiating drugs,
which have equal efﬁcacy. Unfortunately, most TS mea-
sures have not been developed according to appropriate
methodology to ensure reliability and validity. Addition-
ally, as with QoL, the choice to use a generic versus
disease speciﬁc measures can be problematic. This paper
will present and illustrate a solution to this problem by
demonstrating how a generic conceptual framework for
TS can be adapted for a diabetes disease speciﬁc measure.
METHOD: Building on a generic model of TS with
domains of efﬁcacy, side effects, willingness to use/rec-
ommend, impact on daily life, mode of delivery and 
convenience, diabetes disease speciﬁc deﬁnitions of these
domains were derived from patient focus groups and
expert interviews. Existing diabetes TS measures were
examined and limitations were identiﬁed. RESULTS: The
process for developing a generic/disease speciﬁc TS
measure was identiﬁed. Based on this process, a new
disease speciﬁc TS measure, the TSDQ (Treatment 
Satisfaction Diabetes Questionnaire) was developed. The
TSDQ, because it is based on a generic TS conceptual
model, is methodologically sound as well as being con-
ceptually grounded. This paper will identify limitations
with current TS measures, outline the process for 
developing methodological sound generic/disease speciﬁc
TS measures and present the TSDQ development. CON-
CLUSION: Using a generic conceptual model to develop
disease speciﬁc TS measures can help resolve the dilemma
of whether to use a generic or a disease speciﬁc measure.
This hybrid methodology for TS instrument development
will facilitate the promotion of TS claims and help to
solidify the scientiﬁc integrity of TS outcomes.
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OBJECTIVE: A common perspective of health econo-
mists involves the use of QALYs to prioritize activities,
given equal costs. In this mode of thinking, an activity
that took N people from a bad state to healthy for X years
should have priority over an activity that took N other
people from a bad state to a moderate state of health for
X years. In addition to prioritizing based on expected
outcome of the activity, QALY-thinking requires the 
prioritizing of treatment of the young over the old and
the treatment of those with healthy lifestyles over those
with unhealthy lifestyles (both based on longer expected
life-spans). This study was designed to investigate
whether this was the view shared by the general public 
of the United States. METHODS: This was done by 
surveying a cross-spectrum of subjects—including 
physicians, nurses, health administrators, as well as non-
healthcare workers. The survey consisted of six cases in
which the respondent was asked to prioritize two patients
who had presented to the emergency department, both
with life-threatening conditions requiring immediate
intervention. RESULTS: While the number of subjects
leaves room for interpretation, it would appear that inde-
pendent of ﬁeld of work, education level, age or sex,
approximately 80 percent of study participants tended to
emphasize equality in value of life and fairness in receiv-
ing treatment rather than expected quantity or quality of
life-years after the treatment.
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OBJECTIVES: It has been argued that gain in health state
valuation after intervention is smaller from a patient 
perspective than from a nonpatient perspective. In this
study we use hearing impairment as a research model to
test whether illness experience, personal or through
medical experience, inﬂuences gain in health state valua-
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tion after hearing aid ﬁtting. METHODS: The study con-
sisted of a prospective study of ﬁtting hearing aids in
hearing impaired adults (N = 96), with 2 measurements:
before hearing aid ﬁtting, and 12 weeks afterwards. On
both occasions the patients valued and described their
actual hearing related health state. Descriptions of the
health states before and after hearing aid ﬁtting were used
to obtain valuations in: 1) healthy persons without any
illness experience; 2) persons with medical experience
with visual impairment; and 3) persons with medical
experience with hearing impairment (N = 26 each). Data
were tested for between-group differences and inﬂuence
of gender and education level using ANOVA. RESULTS:
The valuations for the health states before and after
hearing aid ﬁtting differed between the groups (p = 0.001
and p = 0.011 respectively). The highest average valua-
tions were observed in the group with medical experience
with hearing impairment. The change in health state 
valuation after intervention was not different between 
the groups (p = 0.295). Gender and education level did
not inﬂuence the results. CONCLUSIONS: The results
conﬁrm that illness experience inﬂuences health state 
valuations. Although the study groups were relatively
small and hence the results should be interpreted with
some caution, as opposed to earlier ﬁndings in this study
persons with experience through medical knowledge 
had higher valuations than patients, and change in health
state after intervention was not inﬂuenced by illness 
experience.
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OBJECTIVES: Objective was to investigate whether
persons with illness experience (personally or through
medical knowledge) use a smaller proportion of the VAS
to value health states than persons without illness expe-
rience. METHODS: The study consisted of a survey in a
patient group: 1) hearing impaired persons (N = 96), and
in three groups without personal illness experience (N =
26 each); 2) persons without illness experience, 3) persons
with medical experience with visual impairment, and 4)
persons with medical experience with hearing impair-
ment. All subjects were asked to value the hypothetical
health states “asthma” (mild state) and “heart failure”
(severe state) on a generic VAS. Results were tested for
between-group differences and inﬂuence of gender and
education level using ANOVA. RESULTS: The valuations
for “asthma” varied from 0.46 (sd 0.18) in the group with
medical experience with hearing impairment to 0.67 (sd
0.20) in the patient group. The valuations differed statis-
tically signiﬁcantly between the groups (p = 0.002). The
valuations for the severe marker state “heart failure”
ranged from 0.19 (sd 0.19) in the patient group to 0.24
(sd 0.17) in the group with medical experience with
hearing impairment. The valuations did not differ 
statistically signiﬁcantly between the groups (p = 0.603).
The patient group used the largest proportion of the 
VAS (0.49), and the group with medical experience with
hearing impairment the smallest proportion (0.21). These
proportions differed statistically signiﬁcantly between the
groups (p = 0.002). Gender and education level did not
inﬂuence the results. CONCLUSIONS: The result did not
conﬁrm that patients use a smaller proportion of the VAS
than persons without illness experience. Since the valua-
tions for “heart” were equal among the groups, this was
largely because the patients had higher valuations for the
mild health state, which is not in concordance with earlier
ﬁndings that personal illness experience leads to lower
valuations for better health states.
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OBJECTIVES: Accurately assessing changes in the
quality of life of elderly people is becoming increasingly
important. Generic instruments are the most popular
method by which to assess quality of life; the EQ-5D in
particular for economic evaluation. However, this instru-
ment has been criticised as having insufﬁcient dimensions,
insensitive scales and concerns over completion rates. A
possibly promising new alternative appeared to be the
Assessment of Quality of Life (AQol) instrument devel-
oped in Australia. This purported to offer greater 
richness in dimensions, and sensitivity to small changes
in quality of life. We describe a “head-to head” compar-
ison of the EQ-5D and AQol. METHODS: As part of a
large trial investigating domiciliary medication review,
the 2 instruments were used to assess changes in health
status in 145 patients over 80 years old. Questionnaires
were administered by researchers at baseline and by post
at three months and six months. This study describes: 
(a) the practicality of using the questionnaires; (b) test 
performance, in terms of construct validity and internal
consistency; (c) agreement of instruments, in terms of
absolute utility scores and changes in scores over follow-
up; and (d) sensitivity to changes in health status.
RESULTS: The EQ-5D proved easy to administer with
good response rates to postal follow-up (81%). 15%
fewer AQol questionnaires were returned fully completed
(95% CI 12–19%). The construct validity appeared to
possibly favour the AQol. However, over 6-months
follow-up the EQ-5D changed by 0.16 units versus AQol
change of 0.12 units (95% CI -0.14 to +0.003). Whilst
the EQ-5D showed moderate sensitivity (effect size of
0.52) the AQol appeared to be poorly sensitive (effect size
of 0.34). CONCLUSION: The results of the analysis pre-
sented in this paper suggest that the EQ-5D is a practical
and sensitive tool with which to assess quality of life
within the elderly.
